Darla E Kendzor1, Michael S Businelle, Insiya B Poonawalla, Erica L Cuate, Anshula Kesh, Debra M Rios, Ping Ma, David S Balis. 1. Darla E. Kendzor, Michael S. Businelle, Insiya B. Poonawalla, Erica L. Cuate, Anshula Kesh, and Debra M. Rios are with the University of Texas Health Science Center, School of Public Health, Dallas. Ping Ma is with the Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas. Davis S. Balis is with the Department of General Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Abstract
OBJECTIVES: We evaluated the effectiveness of offering adjunctive financial incentives for abstinence (contingency management [CM]) within a safety net hospital smoking cessation program. METHODS: We randomized participants (n = 146) from a Dallas County, Texas, Tobacco Cessation Clinic from 2011 to 2013 tousual care (UC; cessation program; n = 71) or CM (UC + 4 weeks of financial incentives; n = 75), and followed from 1 week before the quit date through 4 weeks after the quit date. A subset (n = 128) was asked to attend a visit 12 weeks after the scheduled quit date. RESULTS:Participants were primarily Black (62.3%) or White (28.1%) and female (57.5%). Most participants were uninsured (52.1%) and had an annual household income of less than $12 000 (55.5%). Abstinence rates were significantly higher for those assigned to CM than UC at all visits following the quit date (all Ps < .05). Point prevalence abstinence rates in the CM and UC groups were 49.3% versus 25.4% at 4 weeks after the quit date and 32.8% versus 14.1% at 12 weeks after the quit date. CM participants earned an average of $63.40 ($150 possible) for abstinence during the first 4 weeks after the scheduled quit date. CONCLUSIONS: Offering small financial incentives for abstinence might be an effective means to improve abstinence rates among socioeconomically disadvantaged individuals participating in smoking cessation treatment.
RCT Entities:
OBJECTIVES: We evaluated the effectiveness of offering adjunctive financial incentives for abstinence (contingency management [CM]) within a safety net hospital smoking cessation program. METHODS: We randomized participants (n = 146) from a Dallas County, Texas, Tobacco Cessation Clinic from 2011 to 2013 to usual care (UC; cessation program; n = 71) or CM (UC + 4 weeks of financial incentives; n = 75), and followed from 1 week before the quit date through 4 weeks after the quit date. A subset (n = 128) was asked to attend a visit 12 weeks after the scheduled quit date. RESULTS:Participants were primarily Black (62.3%) or White (28.1%) and female (57.5%). Most participants were uninsured (52.1%) and had an annual household income of less than $12 000 (55.5%). Abstinence rates were significantly higher for those assigned to CM than UC at all visits following the quit date (all Ps < .05). Point prevalence abstinence rates in the CM and UC groups were 49.3% versus 25.4% at 4 weeks after the quit date and 32.8% versus 14.1% at 12 weeks after the quit date. CMparticipants earned an average of $63.40 ($150 possible) for abstinence during the first 4 weeks after the scheduled quit date. CONCLUSIONS: Offering small financial incentives for abstinence might be an effective means to improve abstinence rates among socioeconomically disadvantaged individuals participating in smoking cessation treatment.
Authors: David W Wetter; Ludmila Cofta-Gunn; Jennifer E Irvin; Rachel T Fouladi; Kelli Wright; Patricia Daza; Carlos Mazas; Paul M Cinciripini; Ellen R Gritz Journal: Prev Med Date: 2005-04 Impact factor: 4.018
Authors: Stephen T Higgins; Ira M Bernstein; Yukiko Washio; Sarah H Heil; Gary J Badger; Joan M Skelly; Tara M Higgins; Laura J Solomon Journal: Addiction Date: 2010-09-15 Impact factor: 6.526
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Sarah H Heil; Stephen T Higgins; Ira M Bernstein; Laura J Solomon; Randall E Rogers; Colleen S Thomas; Gary J Badger; Mary Ellen Lynch Journal: Addiction Date: 2008-06 Impact factor: 6.526
Authors: Karen E Lasser; Lisa M Quintiliani; Ve Truong; Ziming Xuan; Jennifer Murillo; Cheryl Jean; Lori Pbert Journal: JAMA Intern Med Date: 2017-12-01 Impact factor: 21.873
Authors: Marlon P Mundt; Timothy B Baker; David L Fraser; Stevens S Smith; Megan E Piper; Michael C Fiore Journal: Value Health Date: 2018-09-20 Impact factor: 5.725
Authors: Matthew D Koslovsky; Emily T Hébert; Michael D Swartz; Wenyaw Chan; Luis Leon-Novelo; Anna V Wilkinson; Darla E Kendzor; Michael S Businelle Journal: Nicotine Tob Res Date: 2018-09-04 Impact factor: 4.244
Authors: Ritabelle Fernandes; Chuan C Chinn; Dongmei Li; Timothy Halliday; Timothy Frankland; Rebecca Rude Ozaki Journal: Hawaii J Med Public Health Date: 2019-01
Authors: Joseph J C Waring; Emily T Hébert; Adam C Alexander; Darla E Kendzor; Michael S Businelle Journal: Addict Behav Date: 2019-08-20 Impact factor: 3.913
Authors: Tricia M Leahey; Jessica Gokee LaRose; Marc S Mitchell; Carnisha M Gilder; Rena R Wing Journal: Am J Prev Med Date: 2018-01-12 Impact factor: 5.043